Registry for the Management and Outcome of Metastatic Spine Tumors

Clinical Trial Title

Metastatic Tumor Research and Outcome Network: A multicenter prospective registry for the management and outcome of metastatic spine tumors.

Contact Information

Clinical Trial Protocol Description:

The registry aims to collect patient information such as patient demographics, co-morbidities, clinical, diagnostic, and therapeutic data, as well as information on adverse events and HRQOL outcomes specific for patients with metastatic spine tumor(s).

Clinical Trial Eligibility Criteria:

In order to participate you must meet the following criteria:

  • Are 18 years of age or older.
  • Have been diagnosed with a metastatic tumor of the spine.
  • Have given informed consent, such as the following:
  1. Ability to understand the content of the patient information/ICF.
  2. Willingness and ability to participate in the registry according to the Registry Plan.
  3. Signed and dated EC/IRB approved written informed consent (if consent is required by the EC/ IRB at the registry site).

You will be excluded from the study if any of the following criteria apply to you:

  • Have been diagnosed with a primary tumor of the spine.

This is a partial list of inclusion and exclusion criteria.

Study Details

Clinical Trial Investigator

John E. O'Toole, MD, MS

Contact Information

Corey Woods


RUSH University Medical Center

1620 W Harrison St
Chicago, IL 60612

Get Directions

Clinical Trial FAQs

Find out if a clinical trial makes sense for you.

Learn more
Learn more